1. Home
  2. NHC vs LEGN Comparison

NHC vs LEGN Comparison

Compare NHC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

N/A

Current Price

$207.18

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$21.69

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NHC
LEGN
Founded
1971
2014
Country
United States
United States
Employees
N/A
3200
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.2B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
NHC
LEGN
Price
$207.18
$21.69
Analyst Decision
Buy
Analyst Count
0
13
Target Price
N/A
★ $45.62
AVG Volume (30 Days)
104.0K
★ 1.9M
Earning Date
11-10-2026
11-10-2026
Dividend Yield
★ 1.26%
N/A
EPS Growth
★ 17.46
N/A
EPS
★ 4.82
N/A
Revenue
★ $1,517,781,000.00
N/A
Revenue This Year
N/A
$39.73
Revenue Next Year
N/A
$23.42
P/E Ratio
$44.20
★ N/A
Revenue Growth
★ 16.09
N/A
52 Week Low
$118.14
$16.24
52 Week High
$248.20
$37.50

Technical Indicators

Market Signals
Indicator
NHC
LEGN
Relative Strength Index (RSI) 36.03 60.31
Support Level $207.60 $17.08
Resistance Level $229.61 $21.99
Average True Range (ATR) 9.19 1.17
MACD -3.70 0.42
Stochastic Oscillator 3.23 71.77

Price Performance

Historical Comparison
NHC
LEGN

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: